Ofev

Fierce Biotech

Avalyn plans IPO to fund ph. 3 trials of inhaled lung drugs

Avalyn Pharma is eyeing an IPO as the biotech seeks more funds to take its inhaled versions of approved drugs for lung conditions into phase 3 trials.

James Waldron Apr 9, 2026 4:13am

Boehringer touts promising launches of Hernexeos, Jascayd

Mar 25, 2026 10:57am

Avalyn adds $100M to advance inhaled versions of IPF pills

Jul 22, 2025 10:44am

Amid US uncertainty, Boehringer projects 'slight' sales increase

Apr 2, 2025 11:32am

Boehringer Ingelheim plots 25 new launches over the next decade

Apr 16, 2024 4:30am

Boehringer Ingelheim IPF ambassador Bernie Williams playing guitar

Boehringer breathes new life into 'Breathless' campaign

Sep 22, 2022 9:20am